William Motley - Profile and Investment Details

Investor Profile

William Motley is a Venture Capital based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics, Constellation Pharmaceuticals, Jounce Therapeutics, Motus Therapeutics, PanOptica, Warp Drive Bio, Editas Medicine, Ember Therapeutics, MOMA Therapeutics, Relay Therapeutics, Decibel Therapeutics, CytomX Therapeutics, Topica Pharmaceuticals, Cibiem, Inc., Alcresta, Rhythm Metabolic, Agios Pharmaceuticals, Rheos Medicines, CMT Research Foundation, Lotus Tissue Repair, Bluebird Bio, Corvia Medical, Afferent Pharmaceuticals, Foundation Medicine, Fulcrum Therapeutics, Voyager Therapeutics, Seventh Sense Biosystems, Palvella Therapeutics, Maze Therapeutics, Neon Therapeutics, TARIS Biomedical, NinePoint Medical, Asher Bio, MyoKardia, Thrive Earlier DetectionCelsius Therapeutics, Igenica, Cedilla Therapeutics, Casma Therapeutics, Flare Therapeutics, Edimer Pharmaceuticals, Pliant Therapeutics, Sesen Bio, Inc., Element Science, Insitro, Soffio Medical, Revolution Medicines, Faze Medicines, Ambys Medicines, Global Blood Therapeutics, Kala Pharmaceuticals, Rhythm Pharmaceuticals, Nurix Therapeutics, Tango Therapeutics, SAGE Therapeutics, Allena Pharmaceuticals, . Over time, William Motley has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether William Motley is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Life Science, Engineering, Biotechnology, Drug Development, Precision Medicine, Neuroscience, Clinical Trials, Research, Health Diagnostics, Regulatory Compliance, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with William Motley, as their portfolio suggests a familiarity and interest in this area.

Understanding William Motley’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.